1 completed, 1 recruiting, 1 withdrawn. 3 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 3 | Completed 1, Recruiting 1, Withdrawn 1 |
Follow Hepatitis, Alcoholic: new trials by email Literature Review of Hepatitis, Alcoholic trials Research Report on Hepatitis, Alcoholic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HA35 Moderate Alcoholic Hepatitis (AH) Study Sodium Hyaluronate, Placebo - Alcoholic Hepatitis | Early Phase 1 | Recruiting | The Cleveland Clinic | 54 | 2022-09-01 | 2026-09-24 |
| Evaluation of HepQuant SHUNT to Assess Liver Disease; Substudy Within GS-US-416-2124 GS-4997, Prednisolone, HepQuant SHUNT Test - Severe Alcoholic Hepatitis | Early Phase 1 | Withdrawn | HepQuant, LLC | 2016-07-31 | 2021-08-30 | |
| Randomised Open-label Multicenter Study Evaluating Ciprofloxacin in Severe Alcoholic Hepatitis Ciprofloxacin, Placebo - Alcoholic Hepatitis, Alcoholic Cirrhosis | Early Phase 1 | Completed | University of Helsinki | 22 | 2015-04-01 | 2017-01-19 |
Fibrosis (1) · Hepatitis (1) · Liver Cirrhosis, Alcoholic (1)
Alcohol-Induced Disorders (3) · Alcohol-Related Disorders (3) · Chemically-Induced Disorders (3) · Digestive System Diseases (3) · Liver Diseases (3) · Liver Diseases, Alcoholic (3) · Substance-Related Disorders (3) · Hepatitis (2) · Liver Cirrhosis (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Ciprofloxacin (1) · Hyaluronic Acid (1) · Prednisolone (1)
HepQuant, LLC (1) · The Cleveland Clinic (1) · University of Helsinki (1)
United States (2) · Finland (1)
Greg Everson, MD (1) · Perttu Sahlman, MD (1)